Treatment Outcomes in Chronic Hepatitis B Patients on Sequential Therapy With Tenofovir Alafenamide (TAF)

Clinical trial NCT03471624 · COMPLETED

Trial details

NCT number: NCT03471624
Sponsor: Stanford University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hepatitis B, Chronic

Start date: 2018-05-01
Primary completion: 2022-04-19
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.